FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Sodium Citrate topics
Sodium Citrate
Citric Acid
Sodium Chloride
Sodium Phosphate
Pemetrexed
Antioxidant
Surfactant
Boric Acid
Phosphoric Acid
Sodium Bicarbonate
Sodium Chlorid
Flow Cytometer
Potassium Chloride
Nickel Sulfate
Sodium Hydroxide

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Sodium Citrate patents



      
           
This page is updated frequently with new Sodium Citrate-related patent applications. Subscribe to the Sodium Citrate RSS feed to automatically get the update: related Sodium RSS feeds. RSS updates for this page: Sodium Citrate RSS RSS


Date/App# patent app List of recent Sodium Citrate-related patents
12/11/14
20140364504
 Broad spectrum pharmacological composition for treatmentof various infections and diseases and methodsof use patent thumbnailBroad spectrum pharmacological composition for treatmentof various infections and diseases and methodsof use
A pharmacological composition for the treatment of bacterial and protozoal infections in a patient. The preferred pharmacological composition comprises a pharmaceutical carrier and an active composition selected from the group consisting of a) an amount of sodium oxalate and an amount of oxalic acid, b) an amount of sodium citrate and an amount of citric acid, or c) mixtures of a) and b).
11/27/14
20140348780
 Method of enhanced antibiotic activity via chemotaxis patent thumbnailMethod of enhanced antibiotic activity via chemotaxis
Compositions and methods for treating infectious diseases produced by biofilms are disclosed. More specifically, the present disclosure refers to a pharmaceutical compositions which may be used for treating biofilm infections, specifically, biofilms formed by bacteria such as pseudomonas, e.
11/06/14
20140329685
 Color stable aqueous formulations containing the potassium salt of (s)-(+)-abscisic acid and methods of their use patent thumbnailColor stable aqueous formulations containing the potassium salt of (s)-(+)-abscisic acid and methods of their use
The present invention generally relates to color stable formulations containing the potassium salt of (s)-(+)-abscisic acid, the color stabilizers sodium citrate and sodium acetate, the antimicrobial agent potassium sorbate, and do not contain an acrylic copolymer surfactant. The present invention is also directed to methods for using the present formulations in organic farming..
09/04/14
20140249030
 Stable and non-precipitating aqueous compositions containing the potassium salt of (s)-(+)-abscisic acid, and methods of their preparation and use patent thumbnailStable and non-precipitating aqueous compositions containing the potassium salt of (s)-(+)-abscisic acid, and methods of their preparation and use
The present invention generally relates to aqueous compositions containing salts of (s)-(+)-abscisic acid, the surfactant atlox™ 4913, and the color stabilizers sodium citrate and sodium acetate, methods of their preparation, and methods of their agricultural use.. .
08/28/14
20140242181
 Preparation of fibrin gel for use as implant system patent thumbnailPreparation of fibrin gel for use as implant system
The present invention aims to generate a fibrin gel for cell proliferation and transport using the patient's own blood or compatible blood. The gel-preparation process consists in taking a quantity of blood from the patient, using sodium citrate as anticoagulant, separating off the citrated plasma by centrifugation, and resuspending the cells to be transported in the plasma.
08/14/14
20140225299
 Solubilized collagen fibers and method for producing the same patent thumbnailSolubilized collagen fibers and method for producing the same
Provided are novel solubilized collagen fibers with which solubilized collagen can be obtained by instantaneous uniform dissolution in water at the time of use. The solubilized collagen fibers are formed from a solubilized collagen solid content of 66 to 87 wt %, buffer salt content of 2 to 6 wt %, water content of 10 to 22 wt %, and a residual hydrophilic organic solvent content of a trace amount of up to 6 wt % (totaling 100 wt %).
07/17/14
20140197106
 Dialysis preparation patent thumbnailDialysis preparation
The present invention provides a pharmaceutical composition for dialysis wherein the decline of ionized calcium concentration in an acetate-free bicarbonate dialysate comprising no acetic acid and/or sodium acetate is controlled. The present invention further provides a dialysis agent a that comprises electrolytes, citric acid and/or citrate as ph adjuster, and/or glucose, for preparation of bicarbonate dialysate; the agent a characterized by being adjusted by citric acid and/or citrate so as to keep the electrolyte ionized calcium concentration not less than 1 mmol/l in a prepared bicarbonate dialysate.
07/03/14
20140186464
 Prophylactic agent and/or therapeutic agent for sepsis patent thumbnailProphylactic agent and/or therapeutic agent for sepsis
The present invention provides a sepsis therapeutic drug useful for prophylaxis and treatment of sepsis. A prophylactic agent and/or a therapeutic agent for sepsis containing 5-aminolevulinic acid (5-ala) or a derivative thereof or a pharmacologically acceptable salt of 5-ala or the derivative as an active ingredient is prepared.
06/26/14
20140179783
 Citrulline-containing beverage patent thumbnailCitrulline-containing beverage
The invention provides an easy-to-drink beverage that contains citrulline, wherein the generation of bad odors due to storage or heating is suppressed. In particular, the invention provides a beverage that contains citrulline, citric acid, sodium citrate, water, and one or more supplements that are saccharides, souring agents, preservatives, colorants, flavoring agents, functional ingredients, or carbon dioxide..
05/01/14
20140117271
Thermally stable flame resistant flexible polyurethane foam
The present invention relates to a reactive formulation used to make a flame resistant flexible polyurethane foam which is particularly suited for use in under the hood vehicle applications which require sound deadening and vibration management and a process to make said foam. Said foam is particularly suitable for such applications because desirable flame resistant properties are achieved after exposure to heat over an extended period of time.
04/03/14
20140093896
Point-of-care, medical condition screening kit
A point-of-care, screening kit for use by a heath care worker to create custom test strips for screening the bodily fluids of an individual for various, medical conditions includes: (a) a plurality of reagents (12), (b) a substrate (18) configured to: i) receive one of the reagents and react with it so as to cause it to acquire a first characteristic color, and, ii) upon the addition of the individual's bodily fluid to the substrate, acquire, as a result of the formulation of each of the reagents, a second, dichotomous characteristic color when the individual has a specific one of the various, medical conditions. This kit also includes: (c) a plurality of containers (10) having indicia (26) that are reflective of the reagent within the container and which of the various medical conditions is being screened for with the use of the container and the characteristic first and second colors which are indicative of the individual having a screened for medical condition, and (d) one of the reagents being a protein reagent that includes appropriate quantities of: water, isopropyl alcohol, citric acid monohydrate, sodium citrate iribasic monohydrate, tetrabromophenol blue and tartrazine..
01/30/14
20140030521
Additive compositions for low loss wire and cable dielectric and products obtained thereby
There are disclosed additive compositions for polymer base materials, which additive compositions are comprised of blowing agent (direct gas or chemical blowing agent), thermoplastic polymer carrier for the chemical blowing agent and filler, wherein the thermoplastic polymer carrier has a melting point below the decomposition temperature of the chemical blowing agent. The chemical blowing agent can be selected from those based on hydrazine, hydrazide, or azodicarbonamide, or those based on combinations of sodium citrate/citric acid and sodium bicarbonate.
01/16/14
20140018298
Citrate free pharmaceutical compositions comprising anakinra
The present invention relates to pharmaceutical compositions comprising anakinra as an active compound in the absence of sodium citrate. The said pharmaceutical compositions are useful for the treatment of il-1 mediated disorders and for decreasing nociceptive pain during such treatment..
11/28/13
20130317112
Storage-stable formulation of paracetamol in aqueous solution
The present invention relates to a method for the production of a formulation that is stable to oxidation and that is based on paracetamol in an aqueous solvent, comprising the steps of (i) dissolving paracetamol in an aqueous solvent comprising an isotonic agent that is sodium chloride and a buffer agent that is sodium citrate, having a temperature between 65° c. And 95° c.
11/28/13
20130315955
Stability and potency of hemagglutinin
The present invention relates to methods of improving the stability and maintaining the potency of recombinant hemagglutinin formulations, in particular, recombinant influenza hemagglutinin (rha). In particular, applicants have shown that the stability of rha formulations may be significantly improved by mutating cysteine residues or by formulating with a reducing agent and sodium citrate..
11/14/13
20130303475
Tobramycin formulation
This invention provides a pharmaceutical solution formulation comprising tobramycin, water, sodium chloride and sodium citrate, wherein the formulation has a ph of 4.5-7.0 and an osmolality of 135-200 mosmol/kg.. .
11/07/13
20130296576
High stable non-ionic n-vinyl butyrolactam iodine and preparation method thereof
The present invention relates to a preparation method of a high-stable non-ionic n-vinyl butyrolactam iodine, wherein non-ionic n-vinyl butyrolactam, iodine and at least one grinding aid are stirred at 150-800 r/min at a temperature of 50° c.-90° c. For 1 to 12 hours to prepare the high-stable non-ionic n-vinyl butyrolactam iodine, wherein the k value of the non-ionic n-vinyl butyrolactam is 32±1, the pd value of the main peak of the non-ionic n-vinyl butyrolactam is ≦1.6, the moisture content of the non-ionic n-vinyl butyrolactam is ≦2.5%, preferably, the grinding aid is selected one or several from sodium chloride, sodium citrate, sodium carbonate and sodium phosphate, the amount of the grinding aid added is 0.02 to 2% of the total amount of the non-ionic n-vinyl butyrolactam and the iodine, the non-ionic n-vinyl butyrolactam is pvp-k32, the high-stable non-ionic n-vinyl butyrolactam iodine prepared by the above mentioned method is also provided, the stability of the high-stable non-ionic n-vinyl butyrolactam iodine of the present invention is high, thereby facilitating long-term storage and use, thus the high-stable non-ionic n-vinyl butyrolactam iodine is suitable for large-scale popularization..
09/26/13
20130252985
Flavoring systems for pharmaceutical compositions and methods of making such compositions
A flavoring system for a liquid pharmaceutical composition and pharmaceutical compositions containing such flavoring systems are disclosed. Flavoring systems of the invention include at least one sweetening agent, at least two flavored ingredients, and at least one flavor modifier selected from the group consisting of citric acid, sodium citrate, sodium chloride, and mixtures thereof.
09/05/13
20130231357
Pharmaceutical compositions containing pemetrexed having extended storage stability
Long term storage stable pemetrexed-containing liquid pharmaceutical compositions are disclosed. The compositions can include pemetrexed or pharmaceutically acceptable salts thereof; an antioxidant selected from lipoic acid, dihydrolipoic acid, methionine and mixtures thereof; a chelating agent selected from lactobionic acid, sodium citrate, tribasic and mixtures thereof; and a pharmaceutically acceptable fluid.
08/29/13
20130225705
Flame resistant flexible polyurethane foam
The present invention relates to a reactive formulation used to make a flame resistant flexible polyurethane foam which is particularly suited for use in under the hood vehicle applications which require sound deadening and vibration management and a process to make said foam. In particular, the flame resistant flexible polyurethane foam is made from a reactive formulation comprising an a side comprising (i) one or more organic isocyanate and a b side comprising (ii) one or more isocyanate-reactive component, (iii) a flame retardant component comprising a combination of red phosphorus, expandable graphite, and optionally sodium citrate wherein the flame retardant component does not contain ammonium polyphosphate; and (iv) one or more additional component selected from a catalyst, a blowing agent, a cell opener, a surfactant, a crosslinker, a chain extender, a filler, a colorant, a pigment, an antistatic agent, reinforcing fibers, an antioxidant, a preservative, or an acid scavenger wherein the resulting foam achieves a v-0 rating at 0.5 inch according to underwriters' laboratories standard 94 flammability test..
08/08/13
20130203845
Synergistic, non-equilibrium aldehyde biocides
A disinfectant solution comprising: an aldehyde; a polyol; one or more acetal derivatives formed by reaction of said aldehyde with said polyol; one or more surfactants selected from the general classes anionic, cationic, or non-ionic; one or more ph buffering agents selected from the group consisting of monosodium phosphate, disodium phosphate, trisodium phosphate, sodium tetraborate, sodium bicarbonate, sodium citrate, phosphoric acid, boric acid and citric acid. The invention also relates to a process of producing the disinfectant solution, and a method of disinfecting and/or sterilizing heat sensitive medical devices comprising treating the medical devices with the disinfectant solution of the invention..
06/13/13
20130150663
System and method for sorting cells
Improved flow cytometer system particularly adapted to use for sex-selected sperm sorting include enhanced sheath fluid and other strategies which minimize stress on the sperm cells, including a 2.9 percent sodium citrate sheath solution for bovine species and a hepes bovine gamete media for equine species. Improved collection systems and techniques for the process are described so that commercial applications of sperms samples as well as the resulting animals may be achieved..
06/13/13
20130149737
System and method for sorting cells
Improved flow cytometer system particularly adapted to use for sex-selected sperm sorting include enhanced sheath fluid and other strategies which minimize stress on the sperm cells, including a 2.9 percent sodium citrate sheath solution for bovine species and a hepes bovine gamete media for equine species. Improved collection systems and techniques for the process are described so that commercial applications of sperms samples as well as the resulting animals may be achieved..
05/30/13
20130136806
Compositions for bowel cleansing and use thereof
The present invention relates to a dry composition for reconstitution in water comprising polyethylene glycol (peg), optionally sodium sulphate, citric acid, sodium citrate, sodium chloride, potassium chloride, simethicone, effective for bowel cleansing, in particular of colon, prior to diagnostic, surgical or therapeutical procedures, in particular colonoscopy.. .
05/23/13
20130129863
Lactic acid-fermented egg having reduced egg protein antigenicity through addition of sodium citrate, heating treatment, and lactic acid fermentation, and method for preparing same
The present invention relates to a lactic acid-fermented egg having reduced egg protein antigenicity and improved organoleptic quality through the addition of sodium citrate, heating treatment, and lactic acid bacteria fermentation, and more specifically, to a lactic acid-fermented egg having reduced egg protein antigenicity, which comprises a series of steps of adding to whole egg liquid a fixed amount of filtered water, sugar, and sodium citrate, heating treating and lactic acid-fermenting same, and a method for preparing same. The present invention reduces the antigenicity of ovomucoid and ovalbumin, which are allergy inducing factors existing inside an egg, has excellent solubility, and excellent organoleptic quality..
05/16/13
20130122324
Surface treatment method for aluminum or aluminum alloy and article manufactured by the same
A surface treatment method for aluminum or aluminum alloy includes the following steps: an aluminum or aluminum alloy substrate is provided. A metallic nickel layer is formed on the aluminum or aluminum alloy substrate by replacement reaction using a water solution.
03/28/13
20130079285
Solubilized collagen fibers and method for producing the same
Provided are novel solubilized collagen fibers with which solubilized collagen can be obtained by instantaneous uniform dissolution in water at the time of use. The solubilized collagen fibers are formed from a solubilized collagen solid content of 66 to 87 wt %, buffer salt content of 2 to 6 wt %, water content of 10 to 22 wt %, and a residual hydrophilic organic solvent content of a trace amount of up to 6 wt % (totaling 100 wt %).


Popular terms: [SEARCH]

Sodium Citrate topics: Sodium Citrate, Citric Acid, Sodium Chloride, Sodium Phosphate, Pemetrexed, Antioxidant, Surfactant, Boric Acid, Phosphoric Acid, Sodium Bicarbonate, Sodium Chlorid, Flow Cytometer, Potassium Chloride, Nickel Sulfate, Sodium Hydroxide

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Sodium Citrate for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sodium Citrate with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         



Key IP Translations - Patent Translations



0.2413

2697

0 - 1 - 54